CFO Piskel Sells 162,820 ($3.2M) Of Adaptive Biotechnologies Corp [ADPT]

CFO Kyle Piskel of Adaptive Biotechnologies Corp sold 162,820 shares worth $3.2 million, as disclosed in a Form 4 filed with the SEC. The transaction was part of a prearranged trading plan (10b5-1). Piskel exercised 110,114 shares before selling, with varying expiration dates. His ending holdings are 216,637 shares directly. The Washington Service provides insider trading analysis and data services.